HOMEPRODUCTSCOMPANYCONTACTFAQResearchDictionaryPharmaSign Up FREE or Login

Subashchandrabose Chinnathambi Selected Research

Microtubule-Associated Proteins (Microtubule-Associated Protein 2)

4/2022G-protein coupled purinergic P2Y12 receptor interacts and internalizes TauRD-mediated by membrane-associated actin cytoskeleton remodeling in microglia.
12/2021Baicalein inhibits heparin-induced Tau aggregation by initializing non-toxic Tau oligomer formation.
1/2021The extracellular HDAC6 ZnF UBP domain modulates the actin network and post-translational modifications of Tau.
1/2021Methylation as a key regulator of Tau aggregation and neuronal health in Alzheimer's disease.
7/2020Residue-based propensity of aggregation in the Tau amyloidogenic hexapeptides AcPHF6* and AcPHF6.
6/2020Effect of Melatonin on Tau aggregation and Tau-mediated cell surface morphology.
3/2020Role of dietary fatty acids in microglial polarization in Alzheimer's disease.
1/2020Melatonin Reduces GSK3β-Mediated Tau Phosphorylation, Enhances Nrf2 Nuclear Translocation and Anti-Inflammation.
1/2020G-Protein Coupled Receptors and Tau-different Roles in Alzheimer's Disease.
11/2019Brahmi (Bacopa monnieri): An ayurvedic herb against the Alzheimer's disease.
For more, sign up at right for free...

Join CureHunter, for free Research Interface BASIC access!

Take advantage of free CureHunter research engine access to explore the best drug and treatment options for any disease. Find out why thousands of doctors, pharma researchers and patient activists around the world use CureHunter every day.
Realize the full power of the drug-disease research graph!


Choose Username:
Email:
Password:
Verify Password:
Enter Code Shown:


Subashchandrabose Chinnathambi Research Topics

Disease

35Alzheimer Disease (Alzheimer's Disease)
04/2022 - 11/2008
11Neurodegenerative Diseases (Neurodegenerative Disease)
12/2021 - 01/2015
5Tauopathies
01/2022 - 11/2019
4Neuroinflammatory Diseases
12/2021 - 11/2019
4Amyloid Plaque
12/2021 - 01/2017
3Inflammation (Inflammations)
04/2022 - 01/2020
3Neoplasms (Cancer)
01/2022 - 01/2015
3Neuroblastoma
12/2021 - 07/2019
2Disease Progression
06/2021 - 01/2021
2Memory Disorders (Memory Loss)
01/2020 - 11/2019
2Frontotemporal Dementia (Semantic Dementia)
01/2020 - 08/2012
1Acne Vulgaris
01/2022
1Prion Diseases (Transmissible Spongiform Encephalopathies)
12/2021
1Huntington Disease (Huntington's Disease)
01/2021
1Nervous System Diseases (Neurological Disorders)
11/2019
1Dementia (Dementias)
11/2019
1Cardiovascular Diseases (Cardiovascular Disease)
01/2015
1Corticobasal Degeneration
08/2012
1Progressive Supranuclear Palsy (Steele Richardson Olszewski Syndrome)
08/2012
1Parkinson Disease (Parkinson's Disease)
08/2012

Drug/Important Bio-Agent (IBA)

17Microtubule-Associated Proteins (Microtubule-Associated Protein 2)IBA
04/2022 - 11/2008
14Amyloid (Amyloid Fibrils)IBA
12/2021 - 01/2017
13Proteins (Proteins, Gene)FDA Link
12/2021 - 01/2015
7tau Proteins (tau Protein)IBA
06/2021 - 08/2010
4Protein AggregatesIBA
12/2021 - 01/2018
3Peptides (Polypeptides)IBA
12/2021 - 01/2017
3Phosphotransferases (Kinase)IBA
08/2020 - 01/2015
2Purinergic Receptors (Receptors, Purine)IBA
04/2022 - 11/2020
21-phenyl-3,3-dimethyltriazene (PDT)IBA
01/2022 - 01/2021
2PolyphenolsIBA
12/2021 - 05/2021
2baicaleinIBA
12/2021 - 10/2019
2G-Protein-Coupled Receptors (Receptors, G Protein Coupled)IBA
06/2021 - 01/2020
2Advanced Glycation End ProductsIBA
05/2021 - 01/2020
2MetalsIBA
08/2020 - 10/2019
2MelatoninIBA
01/2020 - 01/2018
2Intrinsically Disordered ProteinsIBA
07/2011 - 11/2008
1Histones (Histone)IBA
01/2022
1GTP Phosphohydrolases (GTPases)IBA
01/2022
1Neuroprotective AgentsIBA
12/2021
1Amyloid beta-PeptidesIBA
12/2021
1Proteasome Endopeptidase Complex (Proteasome)IBA
11/2021
1Pharmaceutical PreparationsIBA
06/2021
1ArrestinsIBA
06/2021
1Monomeric GTP-Binding ProteinsIBA
06/2021
1Pyruvaldehyde (Methylglyoxal)IBA
05/2021
1TeaIBA
05/2021
1CholesterolIBA
05/2021
1Phosphatidylinositols (Phosphatidylinositol)IBA
01/2021
1LipidsIBA
01/2021
1Reactive Oxygen Species (Oxygen Radicals)IBA
11/2020
1Adenosine Diphosphate (ADP)IBA
11/2020
1Adenosine Triphosphate (ATP)IBA
11/2020
1GTP-Binding Proteins (G-Protein)IBA
11/2020
1Nitric Oxide (Nitrogen Monoxide)FDA Link
11/2020
1NickelIBA
08/2020
1Fatty Acids (Saturated Fatty Acids)IBA
03/2020
1Chemokine CX3CL1IBA
01/2020
1Rose BengalIBA
01/2020
1Nootropic Agents (Nootropics)IBA
11/2019
1Oxygen (Dioxygen)IBA
11/2019
1Methylene Blue (Methylthioninium Chloride)FDA Link
11/2019
1Tolonium ChlorideFDA Link
11/2019
1Biomarkers (Surrogate Marker)IBA
10/2019
1CobaltIBA
10/2019
1Amyloidogenic ProteinsIBA
10/2019
1ferric oxide (iron oxide)IBA
07/2019
1Biological ProductsIBA
07/2019
1LimoninsIBA
06/2019
1Molecular Chaperones (Chaperone, Molecular)IBA
11/2018
1PrionsIBA
08/2018
1Amyloid Precursor Protein Secretases (beta-Secretase)IBA
01/2017
1Receptor for Advanced Glycation End ProductsIBA
01/2015

Therapy/Procedure

6Therapeutics
06/2021 - 10/2019